Tenet Healthcare Corporation [NYSE: THC] traded at a high on 07/29/20, posting a 5.41 gain after which it closed the day’ session at $26.88. The company report on July 14, 2020 that Tenet to Report its Second Quarter Results on August 3.
Tenet Healthcare Corporation (NYSE: THC) plans to report results for its second quarter ended June 30, 2020 after the market closes on Monday, August 3, 2020. The company will host a conference call the following morning, Tuesday, August 4, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. The audio archive will be available on Tenet’s website for approximately 30 days.
About Tenet Healthcare.
The results of the trading session contributed to over 2458553 shares changing hands. Over the past one week, the price volatility of Tenet Healthcare Corporation stands at 4.88% while the volatility over the past one month is 6.65%.
The market cap for THC stock reached $2.83 billion, with 104.35 million shares outstanding and 102.84 million shares in the current float. Compared to the average trading volume of 2.23M shares, THC reached a trading volume of 2458553 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Tenet Healthcare Corporation [THC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for THC shares is $26.06 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on THC stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Tenet Healthcare Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 11, 2020. The new note on the price target was released on February 26, 2020, representing the official price target for Tenet Healthcare Corporation stock. On November 06, 2019, analysts increased their price target for THC shares from 25 to 36.
The Average True Range (ATR) for Tenet Healthcare Corporation is set at 1.43, with the Price to Sales ratio for THC stock in the period of the last 12 months amounting to 0.15. Price to Free Cash Flow for THC in the course of the last twelve months was 4.09 with Quick ratio for the last quarter at 1.20.
How has THC stock performed recently?
Tenet Healthcare Corporation [THC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.56. With this latest performance, THC shares gained by 47.69% in over the last four-week period, additionally sinking by -21.03% over the last 6 months – not to mention a rise of 12.75% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for THC stock in for the last two-week period is set at 71.55, with the RSI for the last a single of trading hit 80.33, and the three-weeks RSI is set at 66.30 for Tenet Healthcare Corporation [THC]. The present Moving Average for the last 50 days of trading for this stock 21.32, while it was recorded at 25.41 for the last single week of trading, and 25.85 for the last 200 days.
Tenet Healthcare Corporation [THC]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Tenet Healthcare Corporation [THC] shares currently have an operating margin of +9.09 and a Gross Margin at +9.09. Tenet Healthcare Corporation’s Net Margin is presently recorded at -1.32.
Return on Total Capital for THC is now 9.68, given the latest momentum, and Return on Invested Capital for the company is -1.64. Additionally, THC Total Debt to Total Capital is recorded at 102.41, with Total Debt to Total Assets ending up at 67.53.
Reflecting on the efficiency of the workforce at the company, Tenet Healthcare Corporation [THC] managed to generate an average of -$2,139 per employee. Receivables Turnover for the company is 5.99 with a Total Asset Turnover recorded at a value of 0.81.Tenet Healthcare Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.30.
Earnings analysis for Tenet Healthcare Corporation [THC]
With the latest financial reports released by the company, Tenet Healthcare Corporation posted 0.56/share EPS, while the average EPS was predicted by analysts to be reported at 0.44/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 27.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for THC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Tenet Healthcare Corporation go to 11.76%.
Insider trade positions for Tenet Healthcare Corporation [THC]
There are presently around $2,845 million, or 98.66% of THC stock, in the hands of institutional investors. The top three institutional holders of THC stocks are: GLENVIEW CAPITAL MANAGEMENT, LLC with ownership of 19,735,625, which is approximately 0% of the company’s market cap and around 1.30% of the total institutional ownership; VANGUARD GROUP INC, holding 12,685,987 shares of the stock with an approximate value of $341.0 million in THC stocks shares; and BLACKROCK INC., currently with $324.41 million in THC stock with ownership of nearly -4.459% of the company’s market capitalization.
Positions in Tenet Healthcare Corporation stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 140 institutional holders increased their position in Tenet Healthcare Corporation [NYSE:THC] by around 10,621,161 shares. Additionally, 123 investors decreased positions by around 7,946,866 shares, while 46 investors held positions by with 87,265,387 shares. The mentioned changes placed institutional holdings at 105,833,414 shares, according to the latest SEC report filing. THC stock had 46 new institutional investments in for a total of 2,166,938 shares, while 51 institutional investors sold positions of 3,735,285 shares during the same period.